In vitro evidence suggesting that the toll-like receptor 7 and 8 agonist resiquimod (R-848) unlikely affects drug levels of co-administered compounds
-
Published:2021-07
Issue:
Volume:162
Page:105826
-
ISSN:0928-0987
-
Container-title:European Journal of Pharmaceutical Sciences
-
language:en
-
Short-container-title:European Journal of Pharmaceutical Sciences
Author:
Theile DirkORCID,
Wagner Lelia,
Haefeli Walter E.ORCID,
Weiss Johanna
Subject
Pharmaceutical Science
Reference36 articles.
1. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver;Albermann;Biochem. Pharmacol.,2005
2. Gaining Mechanistic insight into coproporphyrin i as endogenous biomarker for OATP1B-mediated drug-drug interactions using population pharmacokinetic modeling and simulation;Barnett;Clin. Pharmacol. Ther.,2018
3. Ann-Kristin Arvidsson. Effects of herbal medicinal products and food supplements on induction of CYP1A2, CYP3A4 and MDR1 in the human colon carcinoma cell line LS180;Brandin;Phytother. Res.,2007
4. TLR8: the forgotten relative revendicated;Cervantes;Cell. Mol. Immunol.,2012
5. Anti-tumor activity of toll-like receptor 7 agonists;Chi;Front. Pharmacol.,2017
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献